Company Filing History:
Years Active: 2015-2017
Title: Bret Stephens - Innovator in Histone Demethylase Inhibitors
Introduction
Bret Stephens is a notable inventor based in Riverton, UT (US). He has made significant contributions to the field of biochemistry, particularly in the development of histone demethylase inhibitors. With a total of four patents to his name, his work focuses on innovative methods for treating disorders related to uncontrolled cellular proliferation, including cancer.
Latest Patents
Bret's latest patents include the invention of substituted (E)-N'-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors. These compounds are designed to treat disorders of uncontrolled cellular proliferation by administering them to mammals in need. Another significant patent involves the same class of compounds, which are useful as inhibitors of lysine-specific histone demethylase, including LSD1. This invention also encompasses synthetic methods for creating these compounds, pharmaceutical compositions, and methods for their application in treating disorders associated with LSD1 dysfunction.
Career Highlights
Bret Stephens is affiliated with the University of Utah Research Foundation, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on cancer treatment and other related disorders.
Collaborations
Bret has collaborated with notable colleagues such as Hariprasad Vankayalapati and Venkataswamy Sorna, contributing to the advancement of their shared research goals.
Conclusion
Bret Stephens stands out as an influential inventor in the realm of histone demethylase inhibitors, with a focus on developing innovative treatments for serious health conditions. His contributions are paving the way for future advancements in medical science.